As CTP works to issue decisions on thousands of products with pending PMTAs, many stakeholders anticipate a subsequent increase in SE Reports being filed. Panelists will discuss this “next generation” of SE Reports, including whether a product approved under a PMTA can be used as a predicate for an SE Report, other potential pathways for companies seeking to bring new products to market, and factors CTP should prioritize in making these decisions.